Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
Champions Oncology (CSBR), a global preclinical and clinical research services provider specializing in oncology solutions, has announced it will release its financial and operational results for the first quarter ended July 31, 2024, on Wednesday, September 11, 2024, after market close. The company will host a conference call to discuss the results at 4:30 P.M. EDT on the same day. Investors can join the call using the provided domestic and international dial-in numbers and access code. A replay of the call will be available via phone or through the company's website within 72 hours of the call.
Champions Oncology (CSBR), un fornitore globale di servizi di ricerca preclinici e clinici specializzato in soluzioni oncologiche, ha annunciato che pubblicherà i suoi risultati finanziari e operativi per il primo trimestre chiuso il 31 luglio 2024, mercoledì 11 settembre 2024, dopo la chiusura del mercato. La società ospiterà una conferenza telefonica per discutere i risultati alle 4:30 P.M. EDT lo stesso giorno. Gli investitori possono partecipare alla chiamata utilizzando i numeri di accesso nazionali e internazionali forniti e il codice di accesso. Una registrazione della chiamata sarà disponibile via telefono o attraverso il sito web della società entro 72 ore dalla chiamata.
Champions Oncology (CSBR), un proveedor global de servicios de investigación preclínica y clínica especializado en soluciones oncológicas, ha anunciado que publicará sus resultados financieros y operativos para el primer trimestre que finalizó el 31 de julio de 2024, el miércoles 11 de septiembre de 2024, después del cierre del mercado. La compañía realizará una llamada de conferencia para discutir los resultados a las 4:30 P.M. EDT el mismo día. Los inversores pueden unirse a la llamada utilizando los números de acceso nacionales e internacionales proporcionados y el código de acceso. Una repetición de la llamada estará disponible por teléfono o a través del sitio web de la compañía dentro de las 72 horas posteriores a la llamada.
Champions Oncology (CSBR)는 종양학 솔루션을 전문으로 하는 글로벌 전임상 및 임상 연구 서비스 제공업체로, 2024년 7월 31일 종료된 첫 분기의 재무 및 운영 결과를 2024년 9월 11일 수요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 동일한 날 오후 4시 30분 EDT에 결과를 논의하기 위해 컨퍼런스 콜을 개최할 예정입니다. 투자자들은 제공된 국내 및 국제 전화 접속 번호와 액세스 코드를 사용하여 통화에 참여할 수 있습니다. 통화의 재생은 전화 또는 회사 웹사이트를 통해 통화 후 72시간 이내에 제공됩니다.
Champions Oncology (CSBR), un fournisseur mondial de services de recherche préclinique et clinique spécialisé dans les solutions en oncologie, a annoncé qu'il publiera ses résultats financiers et opérationnels pour le premier trimestre clos le 31 juillet 2024, le mercredi 11 septembre 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique pour discuter des résultats à 16h30 EDT le même jour. Les investisseurs pourront rejoindre l'appel en utilisant les numéros d'appel nationaux et internationaux fournis ainsi que le code d'accès. Un enregistrement de l'appel sera disponible par téléphone ou via le site web de l'entreprise dans les 72 heures suivant l'appel.
Champions Oncology (CSBR), ein globaler Anbieter von präklinischen und klinischen Forschungsdienstleistungen, der sich auf Onkologie-Lösungen spezialisiert hat, hat angekündigt, dass es seine finanziellen und operativen Ergebnisse für das am 31. Juli 2024 endende erste Quartal am Mittwoch, den 11. September 2024, nach Börsenschluss veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr EDT eine Telefonkonferenz veranstalten, um die Ergebnisse zu diskutieren. Investoren können an der Konferenz teilnehmen, indem sie die bereitgestellten inländischen und internationalen Einwahlnummern sowie den Zugangscode verwenden. Eine Wiederholung des Anrufs wird innerhalb von 72 Stunden nach dem Anruf entweder telefonisch oder über die Website des Unternehmens verfügbar sein.
- None.
- None.
HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the first quarter ended July 31, 2024, on Wednesday, September 11, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 726315. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 51258, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Contact:
Rachel Bunting, MS, MBA
VP, Global Marketing
Marketing@ChampionsOncology.com
SOURCE: Champions Oncology, Inc.
View the original press release on accesswire.com
FAQ
When will Champions Oncology (CSBR) report its Q1 2024 financial results?
What time is the Champions Oncology (CSBR) Q1 2024 earnings call scheduled for?
How can investors access the Champions Oncology (CSBR) Q1 2024 earnings call?
Will there be a replay available for Champions Oncology's (CSBR) Q1 2024 earnings call?
